BRPI0911552B8 - métodos para determinar a presença de um analito de interesse, e de uma pluralidade de analitos de interesse diferentes, e, composição - Google Patents

métodos para determinar a presença de um analito de interesse, e de uma pluralidade de analitos de interesse diferentes, e, composição

Info

Publication number
BRPI0911552B8
BRPI0911552B8 BRPI0911552A BRPI0911552A BRPI0911552B8 BR PI0911552 B8 BRPI0911552 B8 BR PI0911552B8 BR PI0911552 A BRPI0911552 A BR PI0911552A BR PI0911552 A BRPI0911552 A BR PI0911552A BR PI0911552 B8 BRPI0911552 B8 BR PI0911552B8
Authority
BR
Brazil
Prior art keywords
interest
methods
analytes
analyte
determining
Prior art date
Application number
BRPI0911552A
Other languages
English (en)
Inventor
I Schaffer Michael
Atefi Mohammad
Hill Virginia
Original Assignee
Psychemedics Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Psychemedics Corp filed Critical Psychemedics Corp
Publication of BRPI0911552A2 publication Critical patent/BRPI0911552A2/pt
Publication of BRPI0911552B1 publication Critical patent/BRPI0911552B1/pt
Publication of BRPI0911552B8 publication Critical patent/BRPI0911552B8/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/948—Sedatives, e.g. cannabinoids, barbiturates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/94—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving narcotics or drugs or pharmaceuticals, neurotransmitters or associated receptors
    • G01N33/9486—Analgesics, e.g. opiates, aspirine
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2474/00—Immunochemical assays or immunoassays characterised by detection mode or means of detection
    • G01N2474/20—Immunohistochemistry assay

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Hematology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Sampling And Sample Adjustment (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)

Abstract

métodos para determinar a presença de um analito de interesse, de uma pluralidade de analitos de interesse diferentes, e de pelo menos um membro de uma classe de drogas de interesse, composição, e, kit composições e métodos para detectar a presença e/ou quantidade de um ou mais analitos, incluindo analitos tais como drogas de abuso, são fornecidos. as composições incluem dois ou mais analitos associados com uma fase sólida, por exemplo, uma partícula ou uma placa de reservatório múltiplo. as composições e métodos também permitem a determinação simultânea, em tandem ou serial da presença e/ou quantidade de dois ou mais analitos de interesse em uma amostra.
BRPI0911552A 2008-04-29 2009-04-29 métodos para determinar a presença de um analito de interesse, e de uma pluralidade de analitos de interesse diferentes, e, composição BRPI0911552B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US4889208P 2008-04-29 2008-04-29
US61/048892 2008-04-29
PCT/US2009/042061 WO2009134855A1 (en) 2008-04-29 2009-04-29 Solid phase multi-analyte assay

Publications (3)

Publication Number Publication Date
BRPI0911552A2 BRPI0911552A2 (pt) 2019-03-06
BRPI0911552B1 BRPI0911552B1 (pt) 2019-11-05
BRPI0911552B8 true BRPI0911552B8 (pt) 2021-07-27

Family

ID=40802062

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0911552A BRPI0911552B8 (pt) 2008-04-29 2009-04-29 métodos para determinar a presença de um analito de interesse, e de uma pluralidade de analitos de interesse diferentes, e, composição

Country Status (11)

Country Link
US (1) US10539580B2 (pt)
EP (2) EP2623987B1 (pt)
JP (2) JP5564491B2 (pt)
CN (2) CN105675892A (pt)
BR (1) BRPI0911552B8 (pt)
CA (2) CA2723162C (pt)
ES (2) ES2562659T3 (pt)
HK (3) HK1186522A1 (pt)
HU (1) HUE028235T2 (pt)
PL (2) PL2623987T3 (pt)
WO (1) WO2009134855A1 (pt)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2562659T3 (es) 2008-04-29 2016-03-07 Psychemedics Corporation Ensayo de múltiples analitos en fase sólida
CN102323414B (zh) * 2011-06-07 2013-09-11 西安金域医学检验所有限公司 一种苯巴比妥均相酶免疫检测试剂盒及其制备方法
US20140004534A1 (en) 2012-06-28 2014-01-02 Psychemedics Corporation Detection of analytes in hair wash samples
JP2015529199A (ja) * 2012-08-21 2015-10-05 オルソ−クリニカル ダイアグノスティクス，インコーポレイティド パリペリドンハプテンに対する抗体及びその使用
KR20220154245A (ko) 2016-09-16 2022-11-21 다케다 파머수티컬 컴패니 리미티드 접촉 활성화 시스템과 연관된 질환을 위한 대사물질 바이오마커
CN109790313A (zh) * 2016-09-30 2019-05-21 简·探针公司 经等离子体处理的表面上的组合物

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US832917A (en) * 1906-02-26 1906-10-09 George A Macbeth Colored signal-lens.
US6582924B1 (en) * 1987-12-28 2003-06-24 Psychemedics Corporation Hair analysis method
US5324642A (en) * 1987-12-28 1994-06-28 Psychemedics Corporation Ligand assays of enzymatic hair digests
US6022693A (en) * 1987-12-28 2000-02-08 Psychemedics Corporation Hair analysis method
US5466579A (en) * 1987-12-28 1995-11-14 Psychemedics Corporation Hair analysis method
US6949344B1 (en) 1987-12-28 2005-09-27 Psychemical Corporation Hair analysis method
US4956467A (en) * 1988-04-01 1990-09-11 American Cyanamid Company Nucleophilic tertiary organophosphines
JPH01276066A (ja) * 1988-04-28 1989-11-06 Mitsui Petrochem Ind Ltd 免疫検定法による低分子化合物の検出方法
JP2837921B2 (ja) 1990-05-22 1998-12-16 サイケメディクス コーポレイション 毛髪分析法
EP0467078B1 (en) 1990-07-18 1996-05-08 Abbott Laboratories An analyte-subtitute reagent for use in specific binding assay methods, devices and kits
US5712157A (en) 1994-12-20 1998-01-27 University Of Washington Methods and materials for the immunoassay of apolipoprotein(a) and lipoprotein(a)
DE19504198A1 (de) * 1995-02-09 1996-08-14 Behringwerke Ag Kompetitiver Immuntest unter Verwendung komplexierter Analytderivate
US6329566B1 (en) * 1997-05-29 2001-12-11 The General Hospital Corporation Methods for the detection, treatment, and prevention of neurodegeneration
US6231982B1 (en) 1997-12-10 2001-05-15 Dade Behring Inc. Particle reagents having reduced matrix effects and containing an aldehyde-reactive functional group
EP1078265A1 (en) 1998-02-18 2001-02-28 Dade Behring Inc. Chemiluminescent compositions for use in detection of multiple analytes
JPH11248703A (ja) * 1998-03-04 1999-09-17 Sanyo Chem Ind Ltd 遊離ハプテンの免疫学的測定法
GB2339615B (en) * 1998-07-14 2001-02-07 Cozart Bioscience Ltd Screening device and method of screening an immunoassay test
US7297554B2 (en) * 1998-11-18 2007-11-20 Microdiagnostics, Inc. Immunoassay system
JP4288750B2 (ja) * 1999-05-14 2009-07-01 日油株式会社 免疫学的測定方法
US6509196B1 (en) * 2000-01-04 2003-01-21 Response Biomedical Corp. Compensation for non-specific signals in quantitative immunoassays
EP1305632B1 (en) 2000-05-04 2011-07-27 Siemens Healthcare Diagnostics Products GmbH Methods for detection of multiple analytes
US7083925B2 (en) * 2002-01-11 2006-08-01 Schnabel Robert D Method of parentage testing in North American bison, Bison bison and domestic cattle using microsatellite loci
CA2478658C (en) * 2002-03-12 2011-10-18 Japan Science And Technology Agency Sandwich immunoassay kits for detecting ciguatoxin ctx3c
CA2483053A1 (en) * 2002-04-30 2004-10-19 Merck & Co., Inc. Human papillomavirus multiplexed assay
US7195875B2 (en) * 2003-04-18 2007-03-27 Beckman Coulter, Inc. Oligonucleotide pairs for multiplexed binding assays
WO2005017485A2 (en) * 2003-05-22 2005-02-24 Agdia, Inc. Multiplex enzyme-linked immunosorbent assay for detecting multiple analytes
WO2005017192A2 (en) * 2003-08-14 2005-02-24 The General Hospital Corporation Screening for gestational disorders
US7413868B2 (en) * 2003-11-05 2008-08-19 Trellis Bioscience, Inc. Use of particulate labels in bioanalyte detection methods
CN1673745A (zh) * 2003-12-20 2005-09-28 苏冬梅 酶联免疫吸附elisa同步快速测定多项免疫指标的方法
US7618591B2 (en) * 2004-01-28 2009-11-17 Bamburgh Marrsh Llc Specimen sample collection device and test system
GB2404022B (en) * 2004-06-14 2005-08-10 Cozart Bioscience Ltd Competitive assays for the detection of methamphetamine group drugs
US20060166376A1 (en) 2005-01-21 2006-07-27 Craig Alan R Compositions for use as a signal generation component and methods of using same
US7629129B1 (en) * 2005-04-26 2009-12-08 The United States Of America As Represented By The Secretary Of The Army Hair follicle bulb as a biodosimeter
WO2006124456A2 (en) * 2005-05-11 2006-11-23 Embrex, Inc. Competitive particle immunoassay methods utilizing fluorescence microscopy
US7795040B2 (en) * 2006-04-17 2010-09-14 Luminex Corporation Methods, particles, and kits for determining activity of a kinase
CN1885038B (zh) * 2006-07-11 2010-08-18 华南农业大学 一种检测克伦特罗酶联免疫试剂盒及其检测方法与检测前动物组织的制样方法
EP2069790B1 (en) * 2006-11-01 2015-04-29 Beckman Coulter, Inc. Binding surfaces for affinity assays
ES2562659T3 (es) 2008-04-29 2016-03-07 Psychemedics Corporation Ensayo de múltiples analitos en fase sólida
US8084215B2 (en) * 2008-04-29 2011-12-27 Psychemedics Corporation Non-proteolytic method for the determination of analytes in keratinized structures

Also Published As

Publication number Publication date
CA2943923C (en) 2018-02-06
CA2723162C (en) 2016-11-01
US20110118138A1 (en) 2011-05-19
ES2562659T3 (es) 2016-03-07
CA2723162A1 (en) 2009-11-05
JP5564491B2 (ja) 2014-07-30
CN105675892A (zh) 2016-06-15
CN102077094B (zh) 2016-03-09
CN102077094A (zh) 2011-05-25
WO2009134855A1 (en) 2009-11-05
EP2623987B1 (en) 2015-12-30
EP2281204B1 (en) 2014-01-08
JP2014209123A (ja) 2014-11-06
BRPI0911552B1 (pt) 2019-11-05
EP2623987A1 (en) 2013-08-07
HK1155221A1 (zh) 2012-05-11
CA2943923A1 (en) 2009-11-05
JP2011519048A (ja) 2011-06-30
PL2281204T3 (pl) 2014-06-30
JP5890864B2 (ja) 2016-03-22
ES2452473T3 (es) 2014-04-01
US10539580B2 (en) 2020-01-21
HK1186522A1 (zh) 2014-03-14
PL2623987T3 (pl) 2016-07-29
BRPI0911552A2 (pt) 2019-03-06
EP2281204A1 (en) 2011-02-09
HK1154072A1 (en) 2012-04-13
HUE028235T2 (en) 2016-12-28

Similar Documents

Publication Publication Date Title
BRPI0911552B8 (pt) métodos para determinar a presença de um analito de interesse, e de uma pluralidade de analitos de interesse diferentes, e, composição
Galetti et al. Effect of ABCG2/BCRP expression on efflux and uptake of gefitinib in NSCLC cell lines
Tran et al. Glutamine deficiency induces DNA alkylation damage and sensitizes cancer cells to alkylating agents through inhibition of ALKBH enzymes
Misiak et al. Effects of second-generation antipsychotics on selected markers of one-carbon metabolism and metabolic syndrome components in first-episode schizophrenia patients
Weidner et al. Influence of T-2 and HT-2 toxin on the blood-brain barrier in vitro: new experimental hints for neurotoxic effects
BR112014015152A2 (pt) métodos e materiais para a avaliação da perda de heterozigosidade
Rojo et al. Clostridium difficile heterogeneously impacts intestinal community architecture but drives stable metabolome responses
BR112013002236A2 (pt) "substrato polimérico, métodos para fornecer um substrato polimérico, para fabricar um chip, e para analisar, detectar, separar e/ou transportar analitos, chip feito de dois substratos, kits para a fabricação de um chip e para a análise e/ou detecção e/ou separação e/ou transporte de analitos, e, uso de um substrato polimérico."
BRPI0516005A (pt) determinação de concentração em uma camada-barreira de difusão
Bergman et al. Low vitamin D levels are associated with higher opioid dose in palliative cancer patients–results from an observational study in Sweden
BRPI0720361A2 (pt) Método para medir aglutinação de uma ou mais partículas em um ensaio de aglutinação induzida por alvo efetuado em uma câmara de reação, e, kit e dispositivo para medir um ou mais parâmetros de aglutinação de partículas em um ensaio de aglutinação induzida por alvo
BR112014019168A2 (pt) ensaio capaz de detectar de forma não degenerada presença ou ausência de analitos em um único volume de amostra, bem como método de detecção da presença ou ausência de analito dentre uma pluralidade dos mesmos
WO2009077864A3 (en) Compositions and methods of detecting tiabs
WO2012024255A3 (en) Camkk-beta as a target for treating cancer
WO2009129505A3 (en) Compositions, methods, and kits using synthetic probes for determining the presence of a target nucleic acid
GB2451042A (en) Reagents and methods for using human embryonic stem cells to evaluate toxicity of pharmaceutical compounds and other chemicals
WO2008011046A3 (en) Computer systems and methods for selecting subjects for clinical trials
WO2009121032A3 (en) Sample preparation devices and methods for processing analytes
Nammo et al. Genome-wide profiling of histone H3K27 acetylation featured fatty acid signalling in pancreatic beta cells in diet-induced obesity in mice
WO2010051544A3 (en) Rapid homogeneous diagnostic testing platform based on lanthanide fluorescent resonance energy transfer
EP2155185A4 (en) DETECTION OF SUCCINYLACETONE
RU2011106957A (ru) Онкоген nrf2 и его применение
ES2530734T3 (es) Biomarcador en suero bioquímico
EP3320900A3 (en) Marker for determination of sensitivity to anticancer agent
WO2013036754A3 (en) Methods and compositions for diagnosis of ovarian cancer

Legal Events

Date Code Title Description
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B06T Formal requirements before examination [chapter 6.20 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 05/11/2019, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 29/04/2009, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO